Penumbral Imaging-Based Thrombolysis with Tenecteplase Is Feasible up to 24 Hours after Symptom Onset-Reference-Cited by-同舟云学术

Penumbral Imaging-Based Thrombolysis with Tenecteplase Is Feasible up to 24 Hours after Symptom Onset

Published:2018-01-31 Issue:1 Volume:20 Page:122-130
ISSN:2287-6391
Container-title:Journal of Stroke
language:en
Short-container-title:J Stroke

Author:

Kate Mahesh,Wannamaker Robert,Kamble Harsha,Riaz Parnian,Gioia Laura C.,Buck Brian,Jeerakathil Thomas,Smyth Penelope,Shuaib Ashfaq,Emery Derek,Butcher Kenneth

Publisher

Korean Stroke Society

Subject

Cardiology and Cardiovascular Medicine,Clinical Neurology

Link

http://j-stroke.org/upload/pdf/jos-2017-00178.pdf

Reference30 articles.

1. Stroke Code Improves Intravenous Thrombolysis Administration in Acute Ischemic Stroke

2. Time to treatment with recombinant tissue plasminogen activator and outcome of stroke in clinical practice: retrospective analysis of hospital quality assurance data with comparison with results from randomised clinical trials

3. Effect of treatment delay, age, and stroke severity on the effects of intravenous thrombolysis with alteplase for acute ischaemic stroke: a meta-analysis of individual patient data from randomised trials

4. A Randomized Trial of Tenecteplase versus Alteplase for Acute Ischemic Stroke

5. Effects of alteplase beyond 3 h after stroke in the Echoplanar Imaging Thrombolytic Evaluation Trial (EPITHET): a placebo-controlled randomised trial

Cited by 24 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Optimizing Acute Ischemic Stroke Outcomes: The Role of Tenecteplase Before Mechanical Thrombectomy;Clinical Therapeutics;2024-09

2. Revolutionizing Stroke Care: Nanotechnology-Based Brain Delivery as a Novel Paradigm for Treatment and Diagnosis;Molecular Neurobiology;2024-06-03

3. Tenecteplase for Stroke at 4.5 to 24 Hours with Perfusion-Imaging Selection;New England Journal of Medicine;2024-02-22

4. Advanced Imaging for Extended Window Stroke Therapy;Ischemic Stroke Therapeutics;2024

5. Intravenous Thrombolysis;Ischemic Stroke Therapeutics;2024